Spegra 50 200 25 Mg

Name: Spegra 50 200 25 Mg
Brand: BHAVYA ENTERPRISES
Price: 2300 INR
Availability: InStock

Price 2300 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Spegra 50 200 25 Mg Specification

Origin of Medicine
India

Life Span
24 months

Pacakaging (Quantity Per Box)
1 bottle per box

Dosage Form
Oral tablet

Salt Composition
Dolutegravir 50mg, Emtricitabine 200mg, Tenofovir Alafenamide 25mg

Brand Name
Spegra

Indication
Treatment of HIV-1 infection

Packaging Type
Bottle

Drug Type
Prescription

Ingredients
Dolutegravir, Emtricitabine, Tenofovir Alafenamide

Physical Form
Tablets

Function
Antiretroviral therapy

Recommended For
HIV-1 infection

Dosage
As directed by physician

Dosage Guidelines
Take once daily with or without food

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30°C, keep in original container

Imprint
DT ETE

Tablet Color
Light blue

Film Coating
Yes

Bottle Material
HDPE

Route of Administration
Oral

Combination Therapy
Yes

Anti-HIV
Yes

Prescription Required
Yes

Shape
Oval

Spegra 50 200 25 Mg Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Bottles Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Spegra 50 200 25 Mg About

Buy Spegra 50 200 25 Mg for a dazzling leap in HIV treatment. This immaculate oral therapy combines Dolutegravir, Emtricitabine, and Tenofovir Alafenamide in brilliant synergy. Each light blue, oval tablet (imprint: DT ETE) ensures top-quality, prescription-only care with a film coating for smooth intake. Packed in an HDPE bottle of 30 tablets, Spegra offers instant checkout and attractive discounts for eligible customers. Designed for adults with HIV-1, it delivers potent antiretroviral action and convenience. Store below 30C and follow dosage guidelines as your physician recommends.

Advanced Features and Versatile Usage for Spegra 50 200 25 Mg

Spegra 50 200 25 Mg Tablets are expertly crafted for commercial and clinical environments targeting advanced HIV-1 therapy. Their immaculate formulation ensures stable efficacy, while the light blue, film-coated finish offers appealing visual assurance. Ideal for prescription management, these tablets serve as a significant asset in hospital pharmacies, clinics, and health centers, supporting robust combination therapy for adults. The user-focused oval shape supports convenient oral usage, maximizing compliance and therapeutic outcomes in professional settings.

FOB Port Specifications and Domestic Market Value of Spegra 50 200 25 Mg

Order processing for Spegra 50 200 25 Mg is thorough and efficient, with FOB Port dispatch from key locations in India. The brand maintains high market value with consistent demand across the main domestic market and approved certifications. Charges are clear and competitive, ensuring buyers receive validated antiretroviral therapy. Each shipment comes certified for quality and safety, upholding regulatory standards and instilling confidence in healthcare providers and suppliers nationwide.

FAQ's of Spegra 50 200 25 Mg:

Q: How should Spegra 50 200 25 Mg be taken for effective results?

A: Spegra 50 200 25 Mg should be taken orally once daily, with or without food, exactly as directed by your prescribing physician for optimal efficacy.

Q: What is the main benefit of using Spegra 50 200 25 Mg in HIV-1 therapy?

A: The main benefit is its brilliant combination of three potent antiretroviral agents, providing comprehensive control over HIV-1 infection and reducing viral load in adults.

Q: Where can I buy Spegra 50 200 25 Mg with instant checkout and discounts?

A: You can purchase Spegra 50 200 25 Mg from authorized pharmacies, suppliers, or traders in India, often benefitting from instant checkout systems and available discounts.

Q: What certifications support the quality of Spegra 50 200 25 Mg?

A: Spegra is shipped with recognized certifications, ensuring compliance with local health regulations and pharmaceutical quality standards for safety and efficacy.

Q: When should Spegra 50 200 25 Mg be used as part of HIV-1 treatment?

A: Spegra is recommended for adults diagnosed with HIV-1 infection as part of a combination antiretroviral therapy regimen, following your healthcare provider's guidance.

Tell us about your requirement